US Stock MarketDetailed Quotes

SNN Smith & Nephew

Watchlist
  • 26.710
  • +0.190+0.72%
Trading Apr 24 11:01 ET
11.69BMarket Cap28.41P/E (TTM)

About Smith & Nephew Company

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

Company Profile

SymbolSNN
Company NameSmith & Nephew
Listing DateNov 16, 1999
Founded1856
CEOMr. Deepak S. Nath
MarketNYSE
Employees17349
Securities TypeDR
ADS Ratio1.0 : 2.0
Fiscal Year Ends12-31
AddressCroxley Park,Hatters Lane,Building 5
CityWatford
ProvinceHerefordshire
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeWD18 8YE
Phone44-1923-477-100

Company Executives

  • Name
  • Position
  • Salary
  • Deepak S. Nath
  • Executive Director,Chief Executive Officer
  • 7.81M
  • John Terence Rogers
  • Executive Director,Chief Financial Officer
  • 2.00M
  • Rupert C Soames OBE
  • Non-Executive Director,Chairman
  • 579.00K
  • Sybella Jane Stanley
  • Non-Executive Director
  • --
  • Joanna Christine Hallas
  • Non-Executive Director
  • 96.00K
  • Angie Risley
  • Non-Executive Director,Senior Independent Non-executive Director
  • 129.00K
  • Simon Jonathan Lowth
  • Non-Executive Director
  • 92.00K
  • Robert J. White
  • Non-Executive Director
  • 169.00K
  • Marc E. Owen
  • Non-Executive Director
  • 198.00K
  • Jeremy Kim Maiden
  • Non-Executive Director
  • 116.00K
  • Dr. Katarzyna Mazur-Hofsaess, PhD
  • Non-Executive Director
  • 96.00K
  • Dr. John Ma
  • Non-Executive Director
  • 176.00K
  • Helen Barraclough
  • Company Secretary & General Council
  • --

Market Insights

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More